ReviewExperimental & molecular medicine2026
Decoding T cell exhaustion in the tumour microenvironment.
Review in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
T cell exhaustion arises during chronic antigen stimulation and represents a major barrier to effective anti-tumour immunity. Rather than a uniform dysfunctional state, exhaustion is increasingly understood as a structured differentiation landscape that progresses from stem-like progenitor exhausted T cells to terminally exhausted T cells. Stem-like progenitor exhausted T cells retain self-renewal capacity and partial effector function, whereas terminally exhausted T cells exhibit epigenetically fixed dysfunction and limited cytokine production. Within the tumour microenvironment, persistent antigen stimulation, together with metabolic stressors such as hypoxia and nutrient deprivation, accelerates this differentiation trajectory, thereby constraining protective immunity. In this review, we conceptualize T cell exhaustion as a dynamic continuum shaped by both differentiation states and microenvironmental niches. We outline an integrative framework to define exhaustion by combining antigen experience, cellular phenotype, functional capacity, epigenetic fixation and spatial context. Viewing immunotherapies through this multidimensional framework highlights the notion that durable therapeutic responses depend on preserving stem-like progenitor exhausted T cells within supportive niches and preventing their terminal differentiation. Understanding how these cellular states are maintained or disrupted within the tumour microenvironment will provide new opportunities for designing therapies that sustain protective T cell immunity in cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.